CancerCare Co-pay Assistance for Myeloproliferative Neoplasms
CancerCare
OpenVerified·Apr 25, 2026
- Covers
- transportationfinancial assistance
- Max income (FPL)
- 500%
- Enrollment cycle
- unknown
Eligibility
Patients must be diagnosed with Myeloproliferative Neoplasms (ET, PV, or MF) and require financial assistance for treatment, co-pays, or clinical trial-related travel. Specific criteria vary by partner organization, with some requiring household income at or below 500% of the federal poverty level.
Apply
Application goes directly to CancerCare. RxCopays does not receive compensation.
Go to application →Status source
CancerCare offers co-pay assistance for patients with Myeloproliferative Neoplasms.
Rare-disease support beyond financial help
This grant covers 2 rare conditions. For specialists, clinical trials, and patient communities, our sister site UniteRare.org has in-depth pages: